Category: Diabetic Retinopathy

AbbVie makes another gene therapy move, paying $370M to partner with Regenxbio

AbbVie, BioPharma, biopharma nl, Clinical Trials, Daily, deals, Diabetic Retinopathy, Illinois, Maryland, North Chicago, Pharma, Regenxbio, Rockville, SYN, Top Story, wet AMD / September 13, 2021 September 13, 2021

AbbVie will take the lead on commercializing Regenxbio’s gene therapy in wet AMD and diabetic retinopathy. It’s AbbVie’s second major gene therapy deal this year, coming months after it committed $90 million to preclinical-stage Capsida Biotherapeutics.

FDA starts review of Roche’s eye disease drug, setting up 2022 verdict

The FDA has started a priority review of Roche’s bispecific antibody faricimab for two major causes of blindness, preparing for a market showdown with Bayer and Regeneron’s market-leading Eylea. The US regulator will review the drug for both neovascular or ‘wet’ age-related macular degeneration (AMD) and diabetic macular oedema (DME), as well as diabetic retinopathy …

FDA starts review of Roche’s eye disease drug, setting up 2022 verdict Read More »

AbCellera Signs a Multi-Target Collaboration with Amgen to Develop Bispecific Antibodies for the Treatment of Diabetic Retinopathy

AbCellera, Angios, Biotech, Bispecific Antibodies, Diabetic Retinopathy / May 7, 2021 May 7, 2021

Shots: AbCellera will receive equity and research fees and is eligible to receive milestone along with royalties based on the development and commercialization of Abs Angios gets the rights to develop and commercialize therapeutic products resulting from the collaboration AbCellera will use an AI-powered platform to generate panels of Abs for up to three Angios-selected …

AbCellera Signs a Multi-Target Collaboration with Amgen to Develop Bispecific Antibodies for the Treatment of Diabetic Retinopathy Read More »

Data-Driven Future: Impact of Machine Learning on Diabetes Management

AI, AI in healthcare, algorithms, Artificial Intelligence, Ascensia Diabetes Care, behavior, bioinformatics, Clinical Trials, cloud, CONTOUR®DIABETES app, diabetes, diabetes app, diabetes management, Diabetic Retinopathy, Digital Healthcare, DreaMed Diabetes, Electronic Medical Records, Genomics, global health, google, healthcare delivery, insulin, Machine Learning, medical records, medication, mobile health, Opinion, Patient Monitoring, radiology, remote patient monitoring, risk, Telehealth, type 1 diabetes, Type 2 Diabetes, Virta Health / March 2, 2021 March 2, 2021

Athar Siddiqui: Global Strategy Lead, Digital Connected Solutions – Ascensia Diabetes Care “Information technology and business are becoming inextricably interwoven. I don’t think anybody can talk meaningfully about one without the talking about the other” – Bill Gates wrote this in 1999 and, nowadays, the same can certainly be said about information technology and healthcare. …

Data-Driven Future: Impact of Machine Learning on Diabetes Management Read More »